ClinVar Miner

Submissions for variant NM_182931.3(KMT2E):c.2261del (p.Leu753_Ser754insTer)

dbSNP: rs1584802161
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV000993724 SCV001146913 likely pathogenic See cases 2019-02-07 criteria provided, single submitter research The heterozygous p.Ser754* variant in KMT2E was identified by our study in one individual with developmental delay. Trio exome analysis showed this variant to be de novo. The p.Ser754* variant in KMT2E has not been previously reported in individuals with developmental delay and was absent from large population studies. This nonsense variant leads to a premature termination codon at position 754 which is predicted to lead to a truncated or absent protein. This alteration is then predicted to lead to a truncated or absent protein. It is of note, that loss of function of the KMT2E gene in autosomal dominant disease has not yet been established based on the criteria laid out in Tayoun, 2018 (PMID: 30192042). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.